# Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/which-comes-first-atypical-antipsychotic-treatment-or-cardiometabolic-risk/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stephen M. Stahl,Laurence Mignon,Jonathan M. Meyer |
| Citations | 260 |
| DOI | 10.1111/j.1600-0447.2008.01334.x |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine,Neuroscience |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1600-0447.2008.01334.x |
| OpenAlex ID | https://openalex.org/W2014202818 |
| PMID | 19178394 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Laurence Mignon](https://scholariq.org/researchers/laurence-mignon/)

## Paper journal

- [Acta Psychiatrica Scandinavica](https://scholariq.org/journals/acta-psychiatrica-scandinavica/)

## Paper primary topic

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)

## Paper topics

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Tryptophan and brain disorders](https://scholariq.org/topics/tryptophan-and-brain-disorders/)
- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.